Delivery at 34 Weeks: Late Preterm Risks, Indications, and Decision-Making
34 weeks = late preterm. This is not term (39–40 weeks). Delivery should be driven by clear maternal or fetal indications, not convenience.
Neonatal Outcomes at 34 Weeks
- Survival: >99% with NICU support.
- Morbidities: Respiratory distress syndrome (30–40%), feeding difficulties, temperature instability, jaundice, apnea, sepsis risk, and higher rehospitalization rates.
- Long-term: Small but measurable increases in neurodevelopmental delay and learning disabilities compared to term infants.
Indications for Delivery
- Maternal: Severe preeclampsia, HELLP syndrome, placental abruption, uncontrolled diabetes, chorioamnionitis.
- Fetal: IUGR with abnormal Dopplers, non-reassuring fetal testing, complications of multiple gestation.
If No Indication Exists
- Continue pregnancy with surveillance (NST, AFI, growth scans).
- Administer corticosteroids (betamethasone) if delivery anticipated before 37 weeks to accelerate lung maturity.
- Magnesium sulfate for neuroprotection if <32 weeks (some protocols extend to 34 weeks).
Shared Decision-Making
Discuss risks of continuing versus delivering with maternal-fetal medicine and obstetrics. Document indication clearly. Avoid elective delivery before 39 weeks.
Pregnancy & Health - Related Articles
- Lysine in Pregnancy: Why High Doses Are Unsafe
- Ectopic Pregnancy: Diagnosis, Medical vs. Surgical Management, and Follow-Up
- Irregular Periods: Causes of Skipped or Frequent Cycles (Non-Pregnancy)
- Missed Periods in Teens: Causes, When to Worry & What to Do
- Medical Abortion Statistics in the US: Trends, Definitions & Data Sources
- Persistently Elevated hCG After Miscarriage: Retained Tissue Suspected
- Conception Date vs. Pregnancy Dating: Understanding the Two-Week Difference
